Original Article
Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2547-2556
.
(31 December 2021)
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2557-2566
.
(31 December 2021)
Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2567-2578
.
(31 December 2021)
Treatment at a high-volume academic research program mitigates racial disparities in pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2579-2590
.
(31 December 2021)
Safety and efficacy of combination chemotherapy regimens in older adults with pancreatic ductal adenocarcinoma: a systematic review
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2591-2599
.
(31 December 2021)
Comprehensive analysis of prognostic value and immune infiltration of calpains in pancreatic cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2600-2621
.
(31 December 2021)
LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2622-2630
.
(31 December 2021)
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2631-2642
.
(31 December 2021)
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2643-2652
.
(31 December 2021)
Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2653-2664
.
(31 December 2021)
A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2665-2674
.
(31 December 2021)
Peripheral blood inflammation indices are effective predictors of anastomotic leakage in elective esophageal surgery
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2675-2684
.
(31 December 2021)
Impact of postoperative lymph node status on the prognosis of esophageal squamous cell carcinoma after esophagectomy following neoadjuvant chemoradiotherapy: a retrospective study
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2685-2695
.
(31 December 2021)
PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2696-2705
.
(31 December 2021)
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2706-2718
.
(31 December 2021)
Microsatellite instability in Chinese gastric cancer and its correlation with clinical characteristics
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2719-2727
.
(31 December 2021)
LncRNA POT1-AS1 accelerates the progression of gastric cancer by serving as a competing endogenous RNA of microRNA-497-5p to increase PDK3 expression
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2728-2742
.
(31 December 2021)
Open distal gastrectomy versus laparoscopic distal gastrectomy for early gastric cancer: a retrospective study
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2743-2748
.
(31 December 2021)
Identification of a 3-gene signature for predicting the prognosis of stage II colon cancer based on microsatellite status
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2749-2762
.
(31 December 2021)
Prognosis of rectal neuroendocrine tumors after endoscopic resection: a single-center retrospective study
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2763-2774
.
(31 December 2021)
Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2775-2787
.
(31 December 2021)
Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2788-2802
.
(31 December 2021)
LncRNA-CASC7 inhibits the proliferation and migration of colon cancer by negatively regulating the PI3K/Akt signaling pathway
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2803-2813
.
(31 December 2021)
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2814-2822
.
(31 December 2021)
Analysis of dynamic molecular networks: the progression from colorectal adenoma to cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2823-2837
.
(31 December 2021)
Combined detection of preoperative neutrophil to lymphocyte ratio and interleukin-6 as an independent prognostic factor for patients with non-metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2838-2845
.
(31 December 2021)
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2846-2853
.
(31 December 2021)
Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2854-2871
.
(31 December 2021)
High expression of MAGE-C1 gene in colorectal cancer is associated with its poor prognosis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2872-2881
.
(31 December 2021)
Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2882-2890
.
(31 December 2021)
A three-phase trans-ethnic study reveals B7-H3 expression is a significant and independent biomarker associated with colon cancer overall survival
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2891-2905
.
(31 December 2021)
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2906-2918
.
(31 December 2021)
A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2919-2929
.
(31 December 2021)
Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2930-2942
.
(31 December 2021)
Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer center
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2943-2951
.
(31 December 2021)
The treatment choices and outcome of hepatocellular carcinoma in hemophilic patients with human immunodeficiency virus/ hepatitis C virus (HIV/HCV) coinfection due to contaminated blood products in Japan
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2952-2959
.
(31 December 2021)
Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2960-2965
.
(31 December 2021)
High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2966-2984
.
(31 December 2021)
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2985-2998
.
(31 December 2021)
Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients
Journal of Gastrointestinal Oncology
2021;
12
(6)
:2999-3007
.
(31 December 2021)
The effect of PPP2CA expression on the prognosis of patients with hepatocellular carcinoma and its molecular biological characteristics
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3008-3021
.
(31 December 2021)
Short-term efficacy of precise hepatectomy and traditional hepatectomy for primary liver cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3022-3032
.
(31 December 2021)
Long noncoding RNA NEAT1 changes exosome secretion and microRNA expression carried by exosomes in hepatocellular carcinoma cells
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3033-3049
.
(31 December 2021)
Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3050-3060
.
(31 December 2021)
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3061-3078
.
(31 December 2021)
ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3079-3092
.
(31 December 2021)
REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3093-3106
.
(31 December 2021)
iMDT Corner
Application of low anterior mediastinal tracheostomy for locally advanced cervicothoracic esophageal cancer undergoing total laryngopharyngoesophagectomy: a case report
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3107-3114
.
(31 December 2021)
Review Article
Pathobiology, irradiation dosimetric parameters and therapy of radiation-induced gastric damage: a narrative review
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3115-3122
.
(31 December 2021)
Educational Case Series of the Memorial Sloan Kettering Cancer Center
Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3123-3132
.
(31 December 2021)
Case Report
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3133-3140
.
(31 December 2021)
Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3141-3147
.
(31 December 2021)
Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3148-3154
.
(31 December 2021)
Circulating tumor-tissue modified HPV DNA analysis for molecular disease monitoring after chemoradiation for anal squamous cell carcinoma: a case report
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3155-3162
.
(31 December 2021)
Letter to the Editor
Commentary: “Magnetic resonance elastography can predict the development of hepatocellular carcinoma: a meta-analysis and systematic review”
Journal of Gastrointestinal Oncology
2021;
12
(6)
:3163-3164
.
(31 December 2021)
